- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 80.04M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $34.79K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $18.45K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $207.52K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $920.16K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $207.52K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $920.16K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $96.5K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $585.02K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $348.29K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $843.72K |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 78.01M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$167.67K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $153.48K |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $270.96K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $78.53K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$619.09K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$635.11K |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $16.91K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $2.2K |
| Revenue | Q1 2024 · Mar 31, 2023 | $19.11K |